New 'Self-Vaccine' injection tested to fight skin cancer before surgery
Disease control
Ongoing
This early-stage study is testing the safety of a new drug called PH-762, which is injected directly into a single skin cancer tumor. The goal is to see if stimulating the immune system locally can help shrink the tumor before it is surgically removed. The study is for adults wit…
Phase: PHASE1 • Sponsor: Phio Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC